ArticleClinical and experimental nephrology2026

Outcomes of tyrosine kinase inhibitor monotherapy for advanced renal cell carcinoma arising in patients with kidney transplantation: comparison with sporadic and end-stage renal disease populations.

Nanaka Katsurayama et al.PubMed ↗Publisher ↗

No numbers read from the abstract.